サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1780724

卵子凍結と胚バンクの世界市場

Egg Freezing and Embryo Banking

出版日
ページ情報
英文 371 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.98円
卵子凍結と胚バンクの世界市場
出版日: 2025年07月31日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 371 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

卵子凍結と胚バンクの世界市場は2030年までに129億米ドルに達する見込み

2024年に52億米ドルと推定される卵子凍結と胚バンクの世界市場は、2024年から2030年にかけてCAGR 16.5％で成長し、2030年には129億米ドルに達すると予測されます。本レポートで分析したセグメントの一つであるドナーは、CAGR18.0％を記録し、分析期間終了時には91億米ドルに達すると予想されます。ノンドナー分野の成長率は、分析期間中CAGR13.4％と推定されます。

米国市場は14億米ドルと推定、中国はCAGR 22.0％で成長予測

米国の卵子凍結と胚バンク市場は、2024年に14億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに29億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは22.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ12.0％と14.9％と予測されています。欧州では、ドイツがCAGR約13.2%で成長すると予測されています。

世界の卵子凍結と胚バンク市場- 主要動向と促進要因のまとめ

卵子凍結と胚バンクが現代のリプロダクティブ・プランニングで脚光を浴びているのはなぜか？

卵子凍結と胚バンクは、現代の生殖能力温存戦略の中心的な要素に急速になりつつあり、いつ、どのように家族を築くかについて、個人やカップルに大きな自主性を提供しています。これらの技術は、体外受精（IVF）のような生殖補助医療による将来の使用のために、未受精卵や受精胚を凍結保存することを含みます。社会的、医学的、経済的要因に後押しされ、これらのサービスの世界の採用は、特にキャリア、個人的、または健康上の理由で出産を遅らせている女性の間で増加しています。女性は卵子凍結を自分の生殖の将来への積極的な投資と考えるようになってきており、一方、胚バンクは体外受精を受けるカップルに、遺伝的に選別された高品質の胚で将来の試みを保証するものです。

凍結保存技術-特にガラス化-における進歩は、凍結卵子と胚の生存率を大幅に改善し、手順をより信頼性と効果的にしています。米国、スペイン、インド、カナダなどの国々では、不妊治療サービスを求める国内外の患者からの需要が急増しています。クリニックは現在、生殖能力を損なう可能性のある化学療法のような治療に直面している女性のために、医学的に適応された選択肢とともに、選択的卵子凍結（社会的凍結とも呼ばれる）を提供しています。一方、胚バンクはまた、卵巣刺激の複数回を避けたい、または妊娠を遅らせたい体外受精患者のための重要な戦略となりつつあります。意識が高まり、より多くの個人が生殖のタイムラインをコントロールできるようになるにつれ、卵子凍結と胚バンクは単なる医療的介入としてではなく、力を与えるライフスタイルの選択として捉えられるようになってきています。

人口動態の変化とライフスタイルの動向はどのように市場拡大を後押ししているのか？

家族構成の変化、子育ての遅れ、性別役割の進化が、卵子凍結と胚バンクの成長を大きく後押ししています。30代から40代前半の女性は、生殖能力の低下という生物学的な現実に直面し、キャリアアップや経済的な安定を追求する一方で、生殖能力を維持するために卵子凍結に目を向けています。同様に、胚バンクは、体外受精の成功率を最適化したり、将来的に複数の子供を計画しようとするカップルによって広く採用されています。LGBTQ+の個人とカップル、選択によるシングルペアレント、治療の前に生殖能力を保護しようとするがん患者もまた、市場を前進させる主要なセグメントになってきています。

不妊治療の選択に対する社会の受容と開放性の高まりは、より多くの人々に、不妊治療を最後の手段としてではなく、積極的に検討するよう促しています。さらに、特にハイテク企業や、従業員福利厚生プログラムの一環として不妊治療特典を提供する大企業による企業支援の高まりは、卵子凍結をより幅広い層にとって経済的に実行可能なものにしています。ソーシャル・メディアのインフルエンサーや公人が不妊治療をオープンにすることで、卵子凍結は正常化し、偏見をなくし、認知度を高めています。クリニックは、医療とカウンセリング、遺伝子スクリーニング、長期保存オプションを組み合わせた、よりパーソナライズされた柔軟なパッケージを提供することで対応しています。不妊治療計画が、ライフスタイル、健康、経済性に影響される、ますます戦略的な意思決定となるにつれ、卵子凍結と胚バンクは、持続的かつ多様な需要の態勢を整えています。

卵子凍結と胚バンクエコシステムを変革する主要プレーヤーとは？

卵子凍結と胚バンクを取り巻く環境は、不妊治療クリニック、バイオテクノロジー企業、デジタルヘルス新興企業、そして世界IVFネットワークの強力な組み合わせによって再構築されつつあります。CCRM（Colorado Center for Reproductive Medicine）、IVI-RMA Global、Nova IVF、Spring Fertilityなどの大手不妊治療チェーンは、臨床結果、技術統合、患者体験のベンチマークを設定しています。これらのセンターは、卵巣刺激、採卵、凍結保存、遺伝子スクリーニング、安全な保管を含む包括的な不妊治療プログラムを提供しています。マイエッグバンク、クライオスインターナショナル、フェアファックスクライオバンクのような卵子バンクや胚保存施設も重要な役割を果たしており、国際配送、ドナーマッチング、長期ケアを備えた集中保管施設を提供しています。

革新的な新興企業は、モバイルモニタリングアプリからAIを活用した胚のグレーディングやブロックチェーンで保護されたクライオストレージまで、あらゆるものを提供し、市場に技術主導のソリューションをもたらしています。胚選択におけるAIと不妊治療結果における予測分析の統合は、成功率と患者の意思決定を大幅に強化しています。さらに、国境を越えた医療ツーリズムは増加傾向にあり、患者は法的枠組みが整備された国で、手頃な価格で利用しやすい不妊治療の選択肢を求めています。ヘルスケアプロバイダー、保険会社、製薬会社間の戦略的提携は、サービス提供を拡大し、手頃な価格を改善しています。教育キャンペーン、患者中心のポータルサイト、バーチャル不妊相談は、アクセスと知識の民主化をさらに進めています。投資の拡大、デジタル化、消費者のエンパワーメントにより、卵子凍結と胚バンク市場は臨床サービスから、テクノロジーを駆使したホリスティックな不妊治療管理プラットフォームへと進化しつつあります。

卵子凍結と胚バンク世界市場の急成長の原動力は？

卵子凍結と胚バンク市場の成長は、技術の進歩、生殖行動の動向、エンドユーザーの期待の進化に結びついた、相互に関連するいくつかの要因によって牽引されています。技術面では、ガラス固化・融解技術の向上により生存率・妊娠率が向上し、卵子・胚保存の臨床効果が大幅に向上しています。着床前遺伝学的検査（PGT）とタイムラプス胚画像の採用は、より良い選択とより高い成功確率を可能にすることで、胚バンクに新たな次元を加えています。一方、スケーラブルな保管インフラと自動化された在庫管理システムは、世界中の施設において安全で長期的な保管を保証しています。

最終用途に関しては、社会的・医学的理由による自発的な妊孕性温存の増加が一貫した需要を牽引しています。結婚や子作りのスケジュールが遅れている都市部の女性が、選択的卵子凍結処置の大きな割合を占めています。がん患者、性別適合治療を受けているトランスジェンダー、余剰胚を保存している体外受精カップルは、多様なユーザー層を形成し、成長しています。アジア太平洋とラテンアメリカにおける不妊治療サービスに対する需要の高まりは、中間所得層の所得拡大と不妊意識に後押しされ、市場をさらに拡大しています。行動面では、価格の透明性、不妊カウンセリングへのアクセスの容易さ、不妊に特化したデジタルヘルスプラットフォームの台頭が、患者の意思決定にプラスの影響を与えています。さらに、雇用主が提供する不妊治療給付金や、地域によっては保険が一部適用されることで、購入しやすい価格が改善され、取り込みが加速しています。こうした医療、行動、構造の力学が相まって、世界の卵子凍結と胚バンク市場の進化と拡大が加速しています。

セグメント

タイプ（ドナー、ノンドナー）;保存（卵子凍結、胚凍結）;患者の年齢（35歳未満、35～37歳、38～40歳、42歳以上）

調査対象企業の例

  • Advanced Fertility Center of Chicago
  • Boston IVF
  • Carrot Fertility
  • CCRM Fertility
  • Cryos International
  • Extend Fertility
  • Genea
  • IVIRMA Global
  • Kindbody
  • Monash IVF Group
  • New Hope Fertility Center
  • NYU Langone Fertility Center
  • Ovation Fertility
  • Pacific Fertility Center
  • Prelude Fertility
  • Progyny
  • ReproTech LLC
  • RMA Network
  • Shady Grove Fertility
  • WINFertility

AI統合

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP30667

Global Egg Freezing and Embryo Banking Market to Reach US$12.9 Billion by 2030

The global market for Egg Freezing and Embryo Banking estimated at US$5.2 Billion in the year 2024, is expected to reach US$12.9 Billion by 2030, growing at a CAGR of 16.5% over the analysis period 2024-2030. Donor, one of the segments analyzed in the report, is expected to record a 18.0% CAGR and reach US$9.1 Billion by the end of the analysis period. Growth in the Nondonor segment is estimated at 13.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 22.0% CAGR

The Egg Freezing and Embryo Banking market in the U.S. is estimated at US$1.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2030 trailing a CAGR of 22.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.0% and 14.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.2% CAGR.

Global Egg Freezing and Embryo Banking Market - Key Trends & Drivers Summarized

Why Is Egg Freezing and Embryo Banking Gaining Prominence in Modern Reproductive Planning?

Egg freezing and embryo banking are rapidly becoming central elements of modern fertility preservation strategies, offering individuals and couples greater autonomy over when and how they choose to build families. These technologies involve cryopreserving unfertilized eggs or fertilized embryos for future use through assisted reproductive procedures like in-vitro fertilization (IVF). Driven by social, medical, and economic factors, the global adoption of these services is on the rise, particularly among women delaying childbirth for career, personal, or health reasons. Women are increasingly viewing egg freezing as a proactive investment in their reproductive futures, while embryo banking offers couples undergoing IVF the assurance of future attempts with genetically screened, high-quality embryos.

Advances in cryopreservation techniques-especially vitrification-have significantly improved the survival rates of frozen eggs and embryos, making the procedures more reliable and effective. Countries like the United States, Spain, India, and Canada are witnessing a surge in demand from both domestic and international patients seeking fertility preservation services. Clinics now offer elective egg freezing (also called social freezing) alongside medically indicated options for women facing treatments like chemotherapy that may impair fertility. Meanwhile, embryo banking is also becoming a key strategy for IVF patients who wish to avoid multiple rounds of ovarian stimulation or wish to delay pregnancy. As awareness grows, and more individuals take control of their reproductive timelines, egg freezing and embryo banking are increasingly viewed not just as medical interventions but as empowering lifestyle choices.

How Are Demographic Shifts and Lifestyle Trends Fueling Market Expansion?

Changing family dynamics, delayed parenthood, and evolving gender roles are significantly driving the growth of egg freezing and embryo banking. Women in their 30s and early 40s-faced with the biological reality of declining fertility-are turning to egg freezing to preserve reproductive potential while pursuing career advancement, financial security, or personal readiness for parenthood. Similarly, embryo banking is being widely adopted by couples seeking to optimize IVF success rates or plan for multiple children in the future. LGBTQ+ individuals and couples, single parents by choice, and cancer patients seeking to safeguard fertility ahead of treatments are also becoming key segments propelling the market forward.

Rising societal acceptance and openness about fertility choices are encouraging more people to consider these services proactively, rather than as a last resort. Additionally, growing corporate support-particularly from tech companies and large employers offering fertility benefits as part of employee wellness programs-is making egg freezing financially viable for a broader demographic. Social media influencers and public figures openly sharing their fertility journeys have also normalized these procedures, reducing stigma and raising awareness. Clinics are responding by offering more personalized, flexible packages that combine medical care with counseling, genetic screening, and long-term storage options. As fertility planning becomes an increasingly strategic decision influenced by lifestyle, health, and economics, egg freezing and embryo banking are poised for sustained and diversified demand.

Who Are the Key Players Transforming the Egg Freezing and Embryo Banking Ecosystem?

The egg freezing and embryo banking landscape is being reshaped by a robust mix of fertility clinics, biotech firms, digital health startups, and global IVF networks. Leading fertility chains such as CCRM (Colorado Center for Reproductive Medicine), IVI-RMA Global, Nova IVF, and Spring Fertility are setting benchmarks in clinical outcomes, technological integration, and patient experience. These centers offer comprehensive fertility preservation programs that include ovarian stimulation, retrieval, cryopreservation, genetic screening, and secure storage. Egg banks and embryo storage facilities such as MyEggBank, Cryos International, and Fairfax Cryobank are also playing a pivotal role, offering centralized repositories with international shipping, donor matching, and long-term care.

Innovative startups are bringing tech-driven solutions to the market, offering everything from mobile monitoring apps to AI-powered embryo grading and blockchain-secured cryo storage. The integration of AI in embryo selection and predictive analytics in fertility outcomes is significantly enhancing success rates and patient decision-making. Additionally, cross-border medical tourism is on the rise, as patients seek affordable and accessible fertility preservation options in countries with supportive legal frameworks. Strategic collaborations between healthcare providers, insurers, and pharmaceutical companies are expanding service offerings and improving affordability. Educational campaigns, patient-centric portals, and virtual fertility consultations are further democratizing access and knowledge. With growing investment, digitization, and consumer empowerment, the egg freezing and embryo banking market is evolving from a clinical service to a holistic, tech-enabled fertility management platform.

What’s Driving the Rapid Growth of the Global Egg Freezing and Embryo Banking Market?

The growth in the egg freezing and embryo banking market is driven by several interrelated factors tied to technological progress, reproductive behavior trends, and evolving end-user expectations. From a technology standpoint, improvements in vitrification and thawing techniques have led to higher survival and pregnancy rates, significantly enhancing the clinical efficacy of both egg and embryo preservation. The adoption of preimplantation genetic testing (PGT) and time-lapse embryo imaging is adding new dimensions to embryo banking by enabling better selection and higher success probabilities. Meanwhile, scalable storage infrastructure and automated inventory management systems are ensuring safe, long-term storage across global facilities.

In terms of end-use, the increase in voluntary fertility preservation for social and medical reasons is driving consistent demand. Women in urban areas with delayed marriage and parenthood timelines are contributing to a large share of elective egg freezing procedures. Cancer patients, transgender individuals undergoing gender-affirming treatments, and IVF couples banking surplus embryos are creating varied and growing user bases. Rising demand for fertility services in Asia-Pacific and Latin America-fueled by expanding middle-class incomes and fertility awareness-is further widening the market. On the behavioral front, transparency in pricing, easier access to fertility counseling, and the rise of fertility-focused digital health platforms are influencing patient decisions positively. Additionally, fertility benefits offered by employers and partial insurance coverage in certain geographies are improving affordability and boosting uptake. Together, these medical, behavioral, and structural dynamics are accelerating the evolution and expansion of the global egg freezing and embryo banking market.

SCOPE OF STUDY:

The report analyzes the Egg Freezing and Embryo Banking market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Donor, Nondonor); Preservation (Egg Freezing, Embryo Freezing); Age of Patient (Under 35 Years, 35-37 Years, 38-40 years, Over 42 years)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Advanced Fertility Center of Chicago
  • Boston IVF
  • Carrot Fertility
  • CCRM Fertility
  • Cryos International
  • Extend Fertility
  • Genea
  • IVIRMA Global
  • Kindbody
  • Monash IVF Group
  • New Hope Fertility Center
  • NYU Langone Fertility Center
  • Ovation Fertility
  • Pacific Fertility Center
  • Prelude Fertility
  • Progyny
  • ReproTech LLC
  • RMA Network
  • Shady Grove Fertility
  • WINFertility

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Egg Freezing and Embryo Banking - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Trend of Delayed Parenthood Among Women Throws the Spotlight On Egg Freezing as a Core Fertility Preservation Strategy
    • Increased Use of Embryo Banking in IVF Treatment Planning Drives Demand for Long-Term Reproductive Flexibility
    • Advances in Vitrification and Cryostorage Technologies Strengthen the Business Case for Reliable Egg and Embryo Preservation
    • Growing Cancer Survivor and At-Risk Patient Populations Propel Growth in Medically Indicated Fertility Preservation Services
    • Corporate Fertility Benefit Programs by Employers Accelerate Access to Elective Egg Freezing Among Working Professionals
    • Expanding Role of Fertility Clinics and Egg Banks Supports Market Scalability Through Integrated Preservation and Retrieval Services
    • Changing Social Norms and Single Parenthood Trends Generate Demand for Personalized Reproductive Planning Options
    • Increased Awareness Through Influencer and Celebrity Advocacy Drives Normalization and Trial of Elective Fertility Freezing
    • Wider Adoption of Genetic Screening and PGT Services Enhances Confidence in Embryo Banking for Future IVF Cycles
    • Rising Demand for Family Planning Flexibility in LGBTQ+ Communities Expands Addressable Market Opportunity for Preservation Services
    • Medical Tourism for Cost-Effective Fertility Preservation Fuels Cross-Border Growth in Egg and Embryo Storage Solutions
    • Digital Health Platforms and AI-Based Fertility Apps Improve User Engagement and Education in Preservation Decision-Making
    • Long-Term Cryostorage Plans and Subscription Models Sustain Growth in Clinic Revenue Streams and Client Retention
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Egg Freezing and Embryo Banking Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Egg Freezing and Embryo Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Egg Freezing and Embryo Banking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Nondonor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Nondonor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Nondonor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Egg Freezing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Egg Freezing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Egg Freezing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Embryo Freezing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Embryo Freezing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Embryo Freezing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Under 35 Years by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Under 35 Years by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Under 35 Years by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for 35-37 Years by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for 35-37 Years by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for 35-37 Years by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for 38-40 years by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for 38-40 years by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for 38-40 years by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Over 42 years by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Over 42 years by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Over 42 years by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Egg Freezing and Embryo Banking Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Type - Donor and Nondonor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Egg Freezing and Embryo Banking by Type - Donor and Nondonor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Egg Freezing and Embryo Banking by Type - Percentage Breakdown of Value Sales for Donor and Nondonor for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Egg Freezing and Embryo Banking by Preservation - Percentage Breakdown of Value Sales for Egg Freezing and Embryo Freezing for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Egg Freezing and Embryo Banking by Age of Patient - Percentage Breakdown of Value Sales for Under 35 Years, 35-37 Years, 38-40 years and Over 42 years for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Type - Donor and Nondonor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Egg Freezing and Embryo Banking by Type - Donor and Nondonor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Egg Freezing and Embryo Banking by Type - Percentage Breakdown of Value Sales for Donor and Nondonor for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Egg Freezing and Embryo Banking by Preservation - Percentage Breakdown of Value Sales for Egg Freezing and Embryo Freezing for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Egg Freezing and Embryo Banking by Age of Patient - Percentage Breakdown of Value Sales for Under 35 Years, 35-37 Years, 38-40 years and Over 42 years for the Years 2015, 2025 & 2030
  • JAPAN
    • Egg Freezing and Embryo Banking Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Type - Donor and Nondonor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Egg Freezing and Embryo Banking by Type - Donor and Nondonor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Egg Freezing and Embryo Banking by Type - Percentage Breakdown of Value Sales for Donor and Nondonor for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Egg Freezing and Embryo Banking by Preservation - Percentage Breakdown of Value Sales for Egg Freezing and Embryo Freezing for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Egg Freezing and Embryo Banking by Age of Patient - Percentage Breakdown of Value Sales for Under 35 Years, 35-37 Years, 38-40 years and Over 42 years for the Years 2015, 2025 & 2030
  • CHINA
    • Egg Freezing and Embryo Banking Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Type - Donor and Nondonor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Egg Freezing and Embryo Banking by Type - Donor and Nondonor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Egg Freezing and Embryo Banking by Type - Percentage Breakdown of Value Sales for Donor and Nondonor for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Egg Freezing and Embryo Banking by Preservation - Percentage Breakdown of Value Sales for Egg Freezing and Embryo Freezing for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Egg Freezing and Embryo Banking by Age of Patient - Percentage Breakdown of Value Sales for Under 35 Years, 35-37 Years, 38-40 years and Over 42 years for the Years 2015, 2025 & 2030
  • EUROPE
    • Egg Freezing and Embryo Banking Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Egg Freezing and Embryo Banking by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Egg Freezing and Embryo Banking by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Type - Donor and Nondonor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Egg Freezing and Embryo Banking by Type - Donor and Nondonor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Egg Freezing and Embryo Banking by Type - Percentage Breakdown of Value Sales for Donor and Nondonor for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Egg Freezing and Embryo Banking by Preservation - Percentage Breakdown of Value Sales for Egg Freezing and Embryo Freezing for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Egg Freezing and Embryo Banking by Age of Patient - Percentage Breakdown of Value Sales for Under 35 Years, 35-37 Years, 38-40 years and Over 42 years for the Years 2015, 2025 & 2030
  • FRANCE
    • Egg Freezing and Embryo Banking Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Type - Donor and Nondonor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Egg Freezing and Embryo Banking by Type - Donor and Nondonor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Egg Freezing and Embryo Banking by Type - Percentage Breakdown of Value Sales for Donor and Nondonor for the Years 2015, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Egg Freezing and Embryo Banking by Preservation - Percentage Breakdown of Value Sales for Egg Freezing and Embryo Freezing for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Egg Freezing and Embryo Banking by Age of Patient - Percentage Breakdown of Value Sales for Under 35 Years, 35-37 Years, 38-40 years and Over 42 years for the Years 2015, 2025 & 2030
  • GERMANY
    • Egg Freezing and Embryo Banking Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Type - Donor and Nondonor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Egg Freezing and Embryo Banking by Type - Donor and Nondonor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Egg Freezing and Embryo Banking by Type - Percentage Breakdown of Value Sales for Donor and Nondonor for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Egg Freezing and Embryo Banking by Preservation - Percentage Breakdown of Value Sales for Egg Freezing and Embryo Freezing for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Egg Freezing and Embryo Banking by Age of Patient - Percentage Breakdown of Value Sales for Under 35 Years, 35-37 Years, 38-40 years and Over 42 years for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Type - Donor and Nondonor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Egg Freezing and Embryo Banking by Type - Donor and Nondonor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Egg Freezing and Embryo Banking by Type - Percentage Breakdown of Value Sales for Donor and Nondonor for the Years 2015, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Egg Freezing and Embryo Banking by Preservation - Percentage Breakdown of Value Sales for Egg Freezing and Embryo Freezing for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Egg Freezing and Embryo Banking by Age of Patient - Percentage Breakdown of Value Sales for Under 35 Years, 35-37 Years, 38-40 years and Over 42 years for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Egg Freezing and Embryo Banking Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Type - Donor and Nondonor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Egg Freezing and Embryo Banking by Type - Donor and Nondonor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for Egg Freezing and Embryo Banking by Type - Percentage Breakdown of Value Sales for Donor and Nondonor for the Years 2015, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Egg Freezing and Embryo Banking by Preservation - Percentage Breakdown of Value Sales for Egg Freezing and Embryo Freezing for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Egg Freezing and Embryo Banking by Age of Patient - Percentage Breakdown of Value Sales for Under 35 Years, 35-37 Years, 38-40 years and Over 42 years for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Type - Donor and Nondonor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Egg Freezing and Embryo Banking by Type - Donor and Nondonor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Spain 15-Year Perspective for Egg Freezing and Embryo Banking by Type - Percentage Breakdown of Value Sales for Donor and Nondonor for the Years 2015, 2025 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Egg Freezing and Embryo Banking by Preservation - Percentage Breakdown of Value Sales for Egg Freezing and Embryo Freezing for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Egg Freezing and Embryo Banking by Age of Patient - Percentage Breakdown of Value Sales for Under 35 Years, 35-37 Years, 38-40 years and Over 42 years for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Type - Donor and Nondonor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Egg Freezing and Embryo Banking by Type - Donor and Nondonor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Russia 15-Year Perspective for Egg Freezing and Embryo Banking by Type - Percentage Breakdown of Value Sales for Donor and Nondonor for the Years 2015, 2025 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Egg Freezing and Embryo Banking by Preservation - Percentage Breakdown of Value Sales for Egg Freezing and Embryo Freezing for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Egg Freezing and Embryo Banking by Age of Patient - Percentage Breakdown of Value Sales for Under 35 Years, 35-37 Years, 38-40 years and Over 42 years for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Type - Donor and Nondonor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Egg Freezing and Embryo Banking by Type - Donor and Nondonor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for Egg Freezing and Embryo Banking by Type - Percentage Breakdown of Value Sales for Donor and Nondonor for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Egg Freezing and Embryo Banking by Preservation - Percentage Breakdown of Value Sales for Egg Freezing and Embryo Freezing for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Egg Freezing and Embryo Banking by Age of Patient - Percentage Breakdown of Value Sales for Under 35 Years, 35-37 Years, 38-40 years and Over 42 years for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Egg Freezing and Embryo Banking Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Egg Freezing and Embryo Banking by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for Egg Freezing and Embryo Banking by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Type - Donor and Nondonor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Egg Freezing and Embryo Banking by Type - Donor and Nondonor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Egg Freezing and Embryo Banking by Type - Percentage Breakdown of Value Sales for Donor and Nondonor for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Egg Freezing and Embryo Banking by Preservation - Percentage Breakdown of Value Sales for Egg Freezing and Embryo Freezing for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Egg Freezing and Embryo Banking by Age of Patient - Percentage Breakdown of Value Sales for Under 35 Years, 35-37 Years, 38-40 years and Over 42 years for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Egg Freezing and Embryo Banking Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Type - Donor and Nondonor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Egg Freezing and Embryo Banking by Type - Donor and Nondonor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Australia 15-Year Perspective for Egg Freezing and Embryo Banking by Type - Percentage Breakdown of Value Sales for Donor and Nondonor for the Years 2015, 2025 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Egg Freezing and Embryo Banking by Preservation - Percentage Breakdown of Value Sales for Egg Freezing and Embryo Freezing for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Egg Freezing and Embryo Banking by Age of Patient - Percentage Breakdown of Value Sales for Under 35 Years, 35-37 Years, 38-40 years and Over 42 years for the Years 2015, 2025 & 2030
  • INDIA
    • Egg Freezing and Embryo Banking Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Type - Donor and Nondonor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Egg Freezing and Embryo Banking by Type - Donor and Nondonor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: India 15-Year Perspective for Egg Freezing and Embryo Banking by Type - Percentage Breakdown of Value Sales for Donor and Nondonor for the Years 2015, 2025 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Egg Freezing and Embryo Banking by Preservation - Percentage Breakdown of Value Sales for Egg Freezing and Embryo Freezing for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Egg Freezing and Embryo Banking by Age of Patient - Percentage Breakdown of Value Sales for Under 35 Years, 35-37 Years, 38-40 years and Over 42 years for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Type - Donor and Nondonor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Egg Freezing and Embryo Banking by Type - Donor and Nondonor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: South Korea 15-Year Perspective for Egg Freezing and Embryo Banking by Type - Percentage Breakdown of Value Sales for Donor and Nondonor for the Years 2015, 2025 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Egg Freezing and Embryo Banking by Preservation - Percentage Breakdown of Value Sales for Egg Freezing and Embryo Freezing for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Egg Freezing and Embryo Banking by Age of Patient - Percentage Breakdown of Value Sales for Under 35 Years, 35-37 Years, 38-40 years and Over 42 years for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Type - Donor and Nondonor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Egg Freezing and Embryo Banking by Type - Donor and Nondonor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Egg Freezing and Embryo Banking by Type - Percentage Breakdown of Value Sales for Donor and Nondonor for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Egg Freezing and Embryo Banking by Preservation - Percentage Breakdown of Value Sales for Egg Freezing and Embryo Freezing for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Egg Freezing and Embryo Banking by Age of Patient - Percentage Breakdown of Value Sales for Under 35 Years, 35-37 Years, 38-40 years and Over 42 years for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Egg Freezing and Embryo Banking Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Egg Freezing and Embryo Banking by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Latin America 15-Year Perspective for Egg Freezing and Embryo Banking by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Type - Donor and Nondonor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Egg Freezing and Embryo Banking by Type - Donor and Nondonor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Egg Freezing and Embryo Banking by Type - Percentage Breakdown of Value Sales for Donor and Nondonor for the Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Egg Freezing and Embryo Banking by Preservation - Percentage Breakdown of Value Sales for Egg Freezing and Embryo Freezing for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Egg Freezing and Embryo Banking by Age of Patient - Percentage Breakdown of Value Sales for Under 35 Years, 35-37 Years, 38-40 years and Over 42 years for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Type - Donor and Nondonor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Egg Freezing and Embryo Banking by Type - Donor and Nondonor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Argentina 15-Year Perspective for Egg Freezing and Embryo Banking by Type - Percentage Breakdown of Value Sales for Donor and Nondonor for the Years 2015, 2025 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Egg Freezing and Embryo Banking by Preservation - Percentage Breakdown of Value Sales for Egg Freezing and Embryo Freezing for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Egg Freezing and Embryo Banking by Age of Patient - Percentage Breakdown of Value Sales for Under 35 Years, 35-37 Years, 38-40 years and Over 42 years for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Type - Donor and Nondonor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Egg Freezing and Embryo Banking by Type - Donor and Nondonor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Brazil 15-Year Perspective for Egg Freezing and Embryo Banking by Type - Percentage Breakdown of Value Sales for Donor and Nondonor for the Years 2015, 2025 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Egg Freezing and Embryo Banking by Preservation - Percentage Breakdown of Value Sales for Egg Freezing and Embryo Freezing for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Egg Freezing and Embryo Banking by Age of Patient - Percentage Breakdown of Value Sales for Under 35 Years, 35-37 Years, 38-40 years and Over 42 years for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Type - Donor and Nondonor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Egg Freezing and Embryo Banking by Type - Donor and Nondonor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Mexico 15-Year Perspective for Egg Freezing and Embryo Banking by Type - Percentage Breakdown of Value Sales for Donor and Nondonor for the Years 2015, 2025 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Egg Freezing and Embryo Banking by Preservation - Percentage Breakdown of Value Sales for Egg Freezing and Embryo Freezing for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Egg Freezing and Embryo Banking by Age of Patient - Percentage Breakdown of Value Sales for Under 35 Years, 35-37 Years, 38-40 years and Over 42 years for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Type - Donor and Nondonor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Egg Freezing and Embryo Banking by Type - Donor and Nondonor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Rest of Latin America 15-Year Perspective for Egg Freezing and Embryo Banking by Type - Percentage Breakdown of Value Sales for Donor and Nondonor for the Years 2015, 2025 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Egg Freezing and Embryo Banking by Preservation - Percentage Breakdown of Value Sales for Egg Freezing and Embryo Freezing for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Egg Freezing and Embryo Banking by Age of Patient - Percentage Breakdown of Value Sales for Under 35 Years, 35-37 Years, 38-40 years and Over 42 years for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Egg Freezing and Embryo Banking Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Egg Freezing and Embryo Banking by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Middle East 15-Year Perspective for Egg Freezing and Embryo Banking by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Type - Donor and Nondonor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Egg Freezing and Embryo Banking by Type - Donor and Nondonor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Egg Freezing and Embryo Banking by Type - Percentage Breakdown of Value Sales for Donor and Nondonor for the Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Egg Freezing and Embryo Banking by Preservation - Percentage Breakdown of Value Sales for Egg Freezing and Embryo Freezing for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Egg Freezing and Embryo Banking by Age of Patient - Percentage Breakdown of Value Sales for Under 35 Years, 35-37 Years, 38-40 years and Over 42 years for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Type - Donor and Nondonor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Egg Freezing and Embryo Banking by Type - Donor and Nondonor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Iran 15-Year Perspective for Egg Freezing and Embryo Banking by Type - Percentage Breakdown of Value Sales for Donor and Nondonor for the Years 2015, 2025 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Egg Freezing and Embryo Banking by Preservation - Percentage Breakdown of Value Sales for Egg Freezing and Embryo Freezing for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Egg Freezing and Embryo Banking by Age of Patient - Percentage Breakdown of Value Sales for Under 35 Years, 35-37 Years, 38-40 years and Over 42 years for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Type - Donor and Nondonor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Egg Freezing and Embryo Banking by Type - Donor and Nondonor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Israel 15-Year Perspective for Egg Freezing and Embryo Banking by Type - Percentage Breakdown of Value Sales for Donor and Nondonor for the Years 2015, 2025 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Egg Freezing and Embryo Banking by Preservation - Percentage Breakdown of Value Sales for Egg Freezing and Embryo Freezing for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Egg Freezing and Embryo Banking by Age of Patient - Percentage Breakdown of Value Sales for Under 35 Years, 35-37 Years, 38-40 years and Over 42 years for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Type - Donor and Nondonor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Egg Freezing and Embryo Banking by Type - Donor and Nondonor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Saudi Arabia 15-Year Perspective for Egg Freezing and Embryo Banking by Type - Percentage Breakdown of Value Sales for Donor and Nondonor for the Years 2015, 2025 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Egg Freezing and Embryo Banking by Preservation - Percentage Breakdown of Value Sales for Egg Freezing and Embryo Freezing for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Egg Freezing and Embryo Banking by Age of Patient - Percentage Breakdown of Value Sales for Under 35 Years, 35-37 Years, 38-40 years and Over 42 years for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Type - Donor and Nondonor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Egg Freezing and Embryo Banking by Type - Donor and Nondonor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: UAE 15-Year Perspective for Egg Freezing and Embryo Banking by Type - Percentage Breakdown of Value Sales for Donor and Nondonor for the Years 2015, 2025 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Egg Freezing and Embryo Banking by Preservation - Percentage Breakdown of Value Sales for Egg Freezing and Embryo Freezing for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Egg Freezing and Embryo Banking by Age of Patient - Percentage Breakdown of Value Sales for Under 35 Years, 35-37 Years, 38-40 years and Over 42 years for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Type - Donor and Nondonor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Egg Freezing and Embryo Banking by Type - Donor and Nondonor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Rest of Middle East 15-Year Perspective for Egg Freezing and Embryo Banking by Type - Percentage Breakdown of Value Sales for Donor and Nondonor for the Years 2015, 2025 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Egg Freezing and Embryo Banking by Preservation - Percentage Breakdown of Value Sales for Egg Freezing and Embryo Freezing for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Egg Freezing and Embryo Banking by Age of Patient - Percentage Breakdown of Value Sales for Under 35 Years, 35-37 Years, 38-40 years and Over 42 years for the Years 2015, 2025 & 2030
  • AFRICA
    • Egg Freezing and Embryo Banking Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Type - Donor and Nondonor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Egg Freezing and Embryo Banking by Type - Donor and Nondonor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Africa 15-Year Perspective for Egg Freezing and Embryo Banking by Type - Percentage Breakdown of Value Sales for Donor and Nondonor for the Years 2015, 2025 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Egg Freezing and Embryo Banking by Preservation - Egg Freezing and Embryo Freezing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Egg Freezing and Embryo Banking by Preservation - Percentage Breakdown of Value Sales for Egg Freezing and Embryo Freezing for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Egg Freezing and Embryo Banking by Age of Patient - Under 35 Years, 35-37 Years, 38-40 years and Over 42 years Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Egg Freezing and Embryo Banking by Age of Patient - Percentage Breakdown of Value Sales for Under 35 Years, 35-37 Years, 38-40 years and Over 42 years for the Years 2015, 2025 & 2030

IV. COMPETITION